Preemptive Treatment of Minimal Residual Disease (MRD) with IL-15-Activated Cytokine-Induced Killer Cells for the Prevention of Relapse in Leukemia Patients after Allogeneic Stem Cell Transplantation – Results of a Pilot Study
2016 ◽
Vol 22
(3)
◽
pp. S43
◽
2013 ◽
Vol 2
(1)
◽
pp. 39-48
◽
2014 ◽
Vol 20
(2)
◽
pp. S85-S86
2009 ◽
Vol 37
(1)
◽
pp. 135-142
◽
2003 ◽
Vol 32
(8)
◽
pp. 791-793
◽